Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-08-14 00:00:00 ET · period of report 2024-08-12 · accession 0001453687-24-000104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-14 | 2024-08-12 | RNAC | BARABE TIMOTHY C | Dir | P - Purchase | $12.70 | +7,500 | 21.8K | +53% | +$95.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | P | A | 7,500 | $12.70 | 21,766 | D | — | — | (F1) On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. |